×
About 4,050 results

ALLMedicine™ Aspergillosis Center

Research & Reviews  1,456 results

Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in ...
https://doi.org/10.1080/14737167.2021.1981862
Expert Review of Pharmacoeconomics & Outcomes Research; Beauchemin C, Guinan K et. al.

Sep 16th, 2021 - BackgroundInvasive mold infections (IMI) directly impact life expectancy, especially with delayed therapy. Among IMI, aspergillosis (IA) is more common than mucormycosis (IM), resulting in IA-targeted empirical treatment with voriconazole for susp...

Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1.
https://doi.org/10.3201/eid2711.211174
Emerging Infectious Diseases; Janssen NAF, Nyga R et. al.

Sep 15th, 2021 - We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in 2 cohorts. Several...

Long Terminal Repeat Retrotransposon Afut4 promotes azole resistance of Aspergillus fum...
https://doi.org/10.1128/AAC.00291-21
Antimicrobial Agents and Chemotherapy; Hu M, Li Z et. al.

Sep 14th, 2021 - Aspergillus fumigatus causes a series of invasive diseases, including the high-mortality invasive aspergillosis, and has been a serious global health threat because of its increased resistance to the first-line clinical triazoles. We analyzed the ...

A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage ...
https://doi.org/10.1183/13993003.01787-2021
The European Respiratory Journal; Agarwal R, Muthu V et. al.

Sep 11th, 2021 - Whether a combination of glucocorticoid and antifungal triazole is superior to glucocorticoid alone, in reducing exacerbations, in patients with allergic bronchopulmonary aspergillosis (ABPA) remains unknown. We aimed to compare the efficacy and s...

see more →

Guidelines  8 results

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 31st, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates a...
https://doi.org/10.1016/j.cmi.2019.05.019
Clinical Microbiology and Infection : the Official Public... Warris A, Lehrnbecher T et. al.

Jun 4th, 2019 - Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer...

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289
Therapeutic Drug Monitoring; Chen K, Zhang X et. al.

Sep 8th, 2018 - Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dos...

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-...
https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection : the Official Public... Ullmann AJ, Aguado JM et. al.

Mar 17th, 2018 - The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis. Of the numero...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

see more →

Drugs  88 results see all →

Clinicaltrials.gov  1 results

Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detection From Aspirate by Ultrasound-guided Fine Needle Aspiration
https://clinicaltrials.gov/ct2/show/NCT01301755

Feb 23rd, 2011 - Invasive aspergillosis is a serious and often fatal infection in patients who are neutropenic or have undergone solid organ or stem cell transplantation. However, early diagnosis of invasive aspergillosis is a challenge. Reiss and Lehmann first de...

see more →

News  66 results

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

Practice-Changing Trials Pave the Way for Novel Approaches in Metastatic Prostate Cancer
https://www.onclive.com/view/practice-changing-trials-pave-the-way-for-novel-approaches-in-metastatic-prostate-cancer

Dec 24th, 2020 - Data from pivotal trials such as CARD and PROfound have led to practice-changing shifts in the treatment of patients with metastatic prostate cancer, according to Joseph Kim, MD, who added that the HERO trial examining the oral gonadotropin-releas...

The COVID Complication You Might Miss
https://www.medscape.com/viewarticle/940740_2

Nov 19th, 2020 - COVID-Associated Pulmonary Aspergillosis (CAPA)   CAPA is a recently recognized complication of COVID-19. Although aspergillosis is classically associated with severely immunocompromised patients, it is increasingly detected in patients who receiv...

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
https://www.mdedge.com/chestphysician/article/210199/cll/pjp-prophylaxis-may-be-unnecessary-cll-patients-btk-inhibitors?channel=234
Sharon Worcester, MDedge News

Oct 16th, 2019 - EDINBURGH – Routine empiric prophylaxis against pneumocystis jiroveci pneumonia (PJP) may be unwarranted in chronic lymphocytic leukemia patients initiating Bruton tyrosine kinase (BTK) inhibitor therapy, a retrospective chart review suggests. Dr.

Myositis Patients at High Risk of Opportunistic Infections
https://www.medpagetoday.com/rheumatology/generalrheumatology/82747

Oct 15th, 2019 - Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found. In a nationally representative cohort study, the incidence...

see more →

Patient Education  1 results see all →